On August 12, 2026, tricuspid‑valve interventional device developer Versa Vascular announced two major adjustments.
On August 10, 2026, foreign‑media reports stated that Shanghai Jieti Medical Technology Co., Ltd. is developing an intravascular‑implantable brain‑computer interface.
On July 28, Zhongke Xianjian co-hosted an IIT clinical investigator meeting on implantable cortical vision restoration brain-computer interfaces together with Shenzhen Eye Hospital, The Second People’s Hospital of Shenzhen, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and
